Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
5.04
+0.07 (1.41%)
At close: Aug 29, 2025, 4:00 PM
4.970
-0.070 (-1.39%)
After-hours: Aug 29, 2025, 7:25 PM EDT

Puma Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
254150206196124408
Upgrade
Market Cap Growth
8.27%-27.32%5.07%57.73%-69.53%19.67%
Upgrade
Enterprise Value
207139233233154420
Upgrade
Last Close Price
5.043.054.334.233.0410.26
Upgrade
PE Ratio
5.184.959.5498021.07--
Upgrade
Forward PE
12.3311.6210.5733.92--
Upgrade
PS Ratio
1.040.650.870.860.491.81
Upgrade
PB Ratio
2.401.633.859.07-50.81-68.55
Upgrade
P/TBV Ratio
4.343.65----
Upgrade
P/FCF Ratio
5.743.857.67-6.02561.16
Upgrade
P/OCF Ratio
5.733.857.63-6.02527.77
Upgrade
EV/Sales Ratio
0.870.610.991.020.611.86
Upgrade
EV/EBITDA Ratio
3.613.285.215.7412.22-
Upgrade
EV/EBIT Ratio
4.504.507.017.58119.32-
Upgrade
EV/FCF Ratio
4.683.598.68-7.45577.31
Upgrade
Debt / Equity Ratio
0.470.802.095.29-47.69-20.32
Upgrade
Debt / EBITDA Ratio
0.811.612.272.546.78-
Upgrade
Debt / FCF Ratio
1.111.914.15-5.65166.37
Upgrade
Asset Turnover
1.191.041.041.021.080.94
Upgrade
Inventory Turnover
7.478.1510.809.4712.0611.89
Upgrade
Quick Ratio
1.541.381.451.591.051.04
Upgrade
Current Ratio
1.731.541.571.731.281.28
Upgrade
Return on Equity (ROE)
63.24%41.60%57.54%0.02%--1042.30%
Upgrade
Return on Assets (ROA)
14.40%8.72%9.19%8.56%0.34%-7.93%
Upgrade
Return on Capital (ROIC)
19.13%11.69%13.82%15.35%0.70%-15.04%
Upgrade
Return on Capital Employed (ROCE)
39.80%26.40%25.40%21.20%1.10%-
Upgrade
Earnings Yield
19.09%20.22%10.48%0.00%-23.43%-14.71%
Upgrade
FCF Yield
17.42%25.96%13.04%-8.07%16.61%0.18%
Upgrade
Buyback Yield / Dilution
-3.94%-3.26%-5.83%-10.56%-2.69%-2.08%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q